Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23940225 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Paclitaxel;   Drug: Doxorubicin

Indicates status has not been verified in more than two years